# EDGAR Filing Document

**Accession Number:** 0001841330
**File Stem:** 0001213900-25-114171
**Filing Date:** 2025-11
**Character Count:** 1976
**Document Hash:** a3313ec8a41b3eab7fe1dc8109205b30
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-114171.hdr.sgml**: 20260407

**ACCESSION NUMBER**: 0001213900-25-114171

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251124

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pasithea Therapeutics Corp.
- **CENTRAL INDEX KEY:** 0001841330
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 851591963
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1111 LINCOLN ROAD, SUITE 500
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139
- **BUSINESS PHONE:** (702) 514-4174

**MAIL ADDRESS:**
- **STREET 1:** 1111 LINCOLN ROAD, SUITE 500
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139

November 24, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Pasithea Therapeutics Corp. (the "Company") <br> Registration Statement on Form S-1 (File No. 333-291611) Filed on November 18, 2025

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on November 21, 2025, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for November 24, 2025, at 9:00 a.m., Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request for acceleration of the effective date.

Please call James O'Grady of Lowenstein Sandler LLP at (646) 414-6849 with any questions.

---

| | |
|:---|:---|
|  | Very truly yours, |
|  | PASITHEA THERAPEUTICS CORP. |
| By: | /s/ Dr. Tiago Reis Marques |
|  | Dr. Tiago Reis Marques |
|  | Chief Executive Officer |

---